$XXII Daily - 22nd Century is a plant #biotechnology company whose #proprietary technology through genetic engineering and plant breeding allows them to increase or decrease the amount of nicotine in the tobacco plant and #cannabis plant. 22nd Century owns or is the exclusive licensee of 129 issued #patents in 78 countries plus an additional 51 pending patent applications, and 22nd Century has co-exclusive rights to another 16 patent applications. Goodrich Tobacco Company, Botanical Genetics, and Hercules Pharmaceuticals are subsidiaries of the company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.